Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Novartis AG (NVS) vs Quantumscape Corp (QS) Price & Performance

Novartis AGTrade
Quantumscape CorpTrade

Price performance (Past 24H)

Key statistics

Novartis AG vs Quantumscape Corp — how do they compare? Novartis AG trades at $153.88 (market cap $290.25B), while Quantumscape Corp trades at $6.07 (market cap $3.62B). The key difference: Novartis AG is far larger — about 80.2× Quantumscape Corp's market cap, and Novartis AG pays a 3.17% dividend while Quantumscape Corp pays none. Which is the better fit depends on your goals.

NVSQS
Market Cap
$290.25B$3.62B
Sector
HealthConsumer Cyclical
52-Week High
$168.62$18.44
52-Week Low
$113.50$5.86
Enterprise Value
$330.27B$2.79B
Dividend Yield
3.17%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Novartis AG

Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.

Read more on NVS

About Quantumscape Corp

QuantumScape Corp is engaged in the development of next-generation solid-state lithium-metal batteries for use in electric vehicles. It developed anode-less cell design, which delivers high energy density while lowering material costs and simplifying manufacturing.

Read more on QS